Unknown

Dataset Information

0

The Impact of Intensive Versus Standard Anthelminthic Treatment on Allergy-related Outcomes, Helminth Infection Intensity, and Helminth-related Morbidity in Lake Victoria Fishing Communities, Uganda: Results From the LaVIISWA Cluster-randomized Trial.


ABSTRACT: BACKGROUND:The prevalence of allergy-related diseases is increasing in low-income countries. Parasitic helminths, common in these settings, may be protective. We hypothesized that intensive, community-wide, anthelminthic mass drug administration (MDA) would increase allergy-related diseases, while reducing helminth-related morbidity. METHODS:In an open, cluster-randomized trial (ISRCTN47196031), we randomized 26 high-schistosomiasis-transmission fishing villages in Lake Victoria, Uganda, in a 1:1 ratio to receive community-wide intensive (quarterly single-dose praziquantel plus albendazole daily for 3 days) or standard (annual praziquantel plus 6 monthly single-dose albendazole) MDA. Primary outcomes were recent wheezing, skin prick test positivity (SPT), and allergen-specific immunoglobulin E (asIgE) after 3 years of intervention. Secondary outcomes included helminths, haemoglobin, and hepatosplenomegaly. RESULTS:The outcome survey comprised 3350 individuals. Intensive MDA had no effect on wheezing (risk ratio [RR] 1.11, 95% confidence interval [CI] 0.64-1.93), SPT (RR 1.10, 95% CI 0.85-1.42), or asIgE (RR 0.96, 95% CI 0.82-1.12). Intensive MDA reduced Schistosoma mansoni infection intensity: the prevalence from Kato Katz examinations of single stool samples from each patient was 23% versus 39% (RR 0.70, 95% CI 0.55-0.88), but the urine circulating cathodic antigen test remained positive in 85% participants in both trial arms. Hookworm prevalence was 8% versus 11% (RR 0.55, 95% CI 0.31-1.00). There were no differences in anemia or hepatospenomegaly between trial arms. CONCLUSIONS:Despite reductions in S. mansoni intensity and hookworm prevalence, intensive MDA had no effect on atopy, allergy-related diseases, or helminth-related pathology. This could be due to sustained low-intensity infections; thus, a causal link between helminths and allergy outcomes cannot be discounted. Intensive community-based MDA has a limited impact in high-schistosomiasis-transmission fishing communities, in the absence of other interventions. CLINICAL TRIALS REGISTRATION:ISRCTN47196031.

SUBMITTER: Sanya RE 

PROVIDER: S-EPMC6495012 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Impact of Intensive Versus Standard Anthelminthic Treatment on Allergy-related Outcomes, Helminth Infection Intensity, and Helminth-related Morbidity in Lake Victoria Fishing Communities, Uganda: Results From the LaVIISWA Cluster-randomized Trial.

Sanya Richard E RE   Nkurunungi Gyaviira G   Hoek Spaans Remy R   Nampijja Margaret M   O'Hara Geraldine G   Kizindo Robert R   Oduru Gloria G   Kabuubi Nakawungu Prossy P   Niwagaba Emmanuel E   Abayo Elson E   Kabagenyi Joyce J   Zziwa Christopher C   Tumusiime Josephine J   Nakazibwe Esther E   Kaweesa James J   Muwonge Kakooza Fred F   Akello Mirriam M   Lubyayi Lawrence L   Verweij Jaco J   Nash Stephen S   van Ree Ronald R   Mpairwe Harriet H   Tukahebwa Edridah E   Webb Emily L EL   Elliott Alison M AM  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20190501 10


<h4>Background</h4>The prevalence of allergy-related diseases is increasing in low-income countries. Parasitic helminths, common in these settings, may be protective. We hypothesized that intensive, community-wide, anthelminthic mass drug administration (MDA) would increase allergy-related diseases, while reducing helminth-related morbidity.<h4>Methods</h4>In an open, cluster-randomized trial (ISRCTN47196031), we randomized 26 high-schistosomiasis-transmission fishing villages in Lake Victoria,  ...[more]

Similar Datasets

| S-EPMC7595614 | biostudies-literature
| S-EPMC4626115 | biostudies-other
| S-EPMC7607714 | biostudies-literature
| S-EPMC7526094 | biostudies-literature
| S-EPMC3723538 | biostudies-literature
| S-EPMC8431852 | biostudies-literature
| S-EPMC5638258 | biostudies-literature
| S-EPMC7232351 | biostudies-literature
| S-EPMC1327676 | biostudies-literature
| S-EPMC8990708 | biostudies-literature